Literature DB >> 12520250

Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery.

Frederick E Barr1, Heidi Beverley, Kristin VanHook, Emma Cermak, Karla Christian, Davis Drinkwater, Karrie Dyer, Noel T Raggio, Jason H Moore, Brian Christman, Marshall Summar.   

Abstract

OBJECTIVE: To test the hypothesis that cardiopulmonary bypass used for repair of ventricular septal defects and atrioventricular septal defects would decrease availability of urea cycle intermediates including arginine and subsequent nitric oxide availability. STUDY
DESIGN: Consecutive infants (n = 26) undergoing cardiopulmonary bypass for repair of an unrestrictive ventricular septal defect or atrioventricular septal defect were studied. Blood samples were collected immediately before surgery, immediately after surgery, and 12 hours, 24 hours, and 48 hours after surgery. Urea cycle intermediates, including citrulline, arginine, and ornithine, were measured by amino acid analysis. Nitric oxide metabolites were measured by means of the modified Griess reaction.
RESULTS: Cardiopulmonary bypass caused a significant decrease in the urea cycle intermediates arginine, citrulline, and ornithine at all postoperative time points compared with preoperative levels. The ratio of ornithine to citrulline, a marker of urea cycle function, was elevated at all postoperative time points compared with preoperative values, indicating decreased urea cycle function. Nitric oxide metabolites were significantly decreased at all postoperative time points except for 48 hours, compared with preoperative levels.
CONCLUSIONS: Cardiopulmonary bypass significantly decreases availability of arginine, citrulline, and nitric oxide metabolites in the postoperative period. Decreased availability of nitric oxide precursors may contribute to the increased risk of postoperative pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520250     DOI: 10.1067/mpd.2003.mpd0311

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Understanding the role of NOS-3 in ventilator-induced lung injury: don't take NO for an answer.

Authors:  Lorraine B Ware; Marshall Summar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-04       Impact factor: 5.464

Review 2.  Inhaled nitric oxide and related therapies.

Authors:  Frederick E Barr; Duncan Macrae
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

3.  Personalized genomic medicine: lessons from the exome.

Authors:  Benjamin D Solomon; Daniel E Pineda-Alvarez; Donald W Hadley; Jamie K Teer; Praveen F Cherukuri; Nancy F Hansen; Pedro Cruz; Alice C Young; Robert W Blakesley; Brendan Lanpher; Stephanie Mayfield Gibson; Murat Sincan; Settara C Chandrasekharappa; James C Mullikin
Journal:  Mol Genet Metab       Date:  2011-07-05       Impact factor: 4.797

Review 4.  Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease.

Authors:  Monnipa Suesaowalak; John P Cleary; Anthony C Chang
Journal:  World J Pediatr       Date:  2010-02-09       Impact factor: 2.764

5.  Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study.

Authors:  Jeffrey A Canter; Marshall L Summar; Heidi B Smith; Geraldine D Rice; Lynn D Hall; Marylyn D Ritchie; Alison A Motsinger; Karla G Christian; Davis C Drinkwater; Frank G Scholl; Karrie L Dyer; Ann L Kavanaugh-McHugh; Frederick E Barr
Journal:  Mitochondrion       Date:  2006-11-29       Impact factor: 4.160

6.  L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.

Authors:  Arul Vadivel; Judy L Aschner; Gloria J Rey-Parra; Jordan Magarik; Heng Zeng; Marshall Summar; Farah Eaton; Bernard Thébaud
Journal:  Pediatr Res       Date:  2010-12       Impact factor: 3.756

7.  Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency?

Authors:  Nicola Brunetti-Pierri; Ayelet Erez; Oleg Shchelochkov; William Craigen; Brendan Lee
Journal:  Mol Genet Metab       Date:  2009-06-13       Impact factor: 4.797

8.  Endothelin-1 and asymmetric dimethylarginine in children with left-to-right shunt after intracardiac repair.

Authors:  Tsvetomir Loukanov; Raoul Arnold; Jasmin Gross; Christian Sebening; Homa Klimpel; Joachim Eichhorn; Katharina Hoss; Herbert E Ulmer; Matthias Kark; Matthias Gorenflo
Journal:  Clin Res Cardiol       Date:  2008-02-22       Impact factor: 5.460

9.  Quantitative RT-PCR comparison of the urea and nitric oxide cycle gene transcripts in adult human tissues.

Authors:  Meaghan Anne Neill; Judy Aschner; Frederick Barr; Marshall L Summar
Journal:  Mol Genet Metab       Date:  2009-03-03       Impact factor: 4.797

Review 10.  Treatment of pediatric pulmonary hypertension.

Authors:  Amy Hawkins; Robert Tulloh
Journal:  Vasc Health Risk Manag       Date:  2009-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.